Nigeria, Jan. 30 -- Drug maker Fidson Healthcare posted a 61.1 per cent surge in net profit last year, compared to 2024, according to i unaudited financials released on Thursday, lifted by Nigeria's fast-growing market for prescription drugs.

Turnover for the pharmaceutical firm quickened by 41.4 per cent to N119.1 billion on the back of higher income from ethical drugs, also known as prescription medicines, which alone accounted for 65.4 per cent of revenue.

The strong result also reflected a shift towards exports as the company earned N523.1 million from sales outside the country.

Fidson had, in September 2024, struck a joint venture deal with Chinese companies Jiangsu Aidea Pharma, Nanjing PharmaBlock, and the Beijing-based China-Af...